Australia
08048030432
+917498304432

Gilteritinib tablets for FLT3-mutated acute myeloid leukemia. Targeted therapy for blood cancer.

LuciGil is used to treat relapsed or refractory acute myeloid leukemia with FLT3 mutation.

Active Ingredient

Gilteritinib inhibits FLT3 receptor signaling.

Uses of LuciGil

• FLT3-positive AML

How LuciGil Works

It blocks FLT3 pathways responsible for cancer cell proliferation.

How to Use LuciGil

• Take once daily

Possible Side Effects

• Fatigue
• Elevated liver enzymes

Precautions

• Monitor heart rhythm
• Regular blood tests

Safety Information

Use under medical supervision.

Storage

• Store at room temperature
• Protect from moisture and sunlight
• Keep out of reach of children 
 2026-03-24T12:12:11

Other Pages

View all pages